Cargando…
A safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma
Cisplatin (CDDP) is an anticancer agent that is commonly used in hepatic arterial infusion (HAI) chemotherapy for hepatocellular carcinoma (HCC). This study aimed to clarify the safe and effective dose of CDDP in HAI for HCC. The hypervascular area was measured in 42 HCCs before and after HAI with C...
Autores principales: | Osaki, Akihiko, Suda, Takeshi, Kamimura, Kenya, Tsuchiya, Atsunori, Tamura, Yasushi, Takamura, Masaaki, Igarashi, Masato, Kawai, Hirokazu, Yamagiwa, Satoshi, Aoyagi, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797567/ https://www.ncbi.nlm.nih.gov/pubmed/24133631 http://dx.doi.org/10.1002/cam4.55 |
Ejemplares similares
-
Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma
por: Kamimura, Kenya, et al.
Publicado: (2012) -
Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial
por: Kamimura, Kenya, et al.
Publicado: (2017) -
Spontaneous regression of hepatocellular carcinoma: A mini-review
por: Sakamaki, Akira, et al.
Publicado: (2017) -
Bleeding from a Small-Intestinal Ulcer Associated with Chronic Hepatitis C
por: Kamimura, Hiroteru, et al.
Publicado: (2018) -
Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses
por: Kamimura, Kenya, et al.
Publicado: (2017)